Tinnitus Patient Preferences Survey

NCT06782308 | Recruiting

• 1 other identifier: TEP-03301
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this survey is to assess several aspects related to patient preferences regarding interventions for alleviating tinnitus through invasive electrical brain stimulation (neuromodulation). This survey covers the acceptance of a surgically-placed brain implant, of its associated risks related to the neurosurgical procedure, usability considerations, and the willingness/ability to pay for such a treatment. Neurosoft Bioelectronics will use the collected patients' feedback and usability preferences data for the development of a novel minimally invasive brain implant aimed at alleviating tinnitus.

Conditions

Tinnitus, Subjective; Tinnitus, Bilateral; Tinnitus, Noise Induced; Tinnitus, Hearing Loss, Cochlear Implant Users

Keywords

tinnitus; iBCI; brain implant; survey; risks acceptance; user preferences; patient preferences; subjective tinnitus; chronic tinnitus; severe tinnitus; catastrophic tinnitus; invasive neuromodulation; surgical treatment

Outcome Measures

Primary Outcomes (1)

• Acceptance of invasive neuromodulation treatments for chronic tinnitus

  Risks acceptance and user preferences will be assessed through responses to the survey. The outcome will be summarized in the form of a percentage or similar statistics on acceptances rates for surgical interventions in patients with chronic tinnitus. Acceptance rates will also be evaluated in accordance to several clinical characteristics of tinnitus, such as its perceived annoyance or loudness.

  1 year

Secondary Outcomes (2)

• Usability preferences for implantable neuromodulation systems for chronic tinnitus

  1 year

• Willingness and ability to pay for novel invasive neuromodulation solutions for chronic tinnitus

  1 year

Study Arms (1)

patients with tinnitus

Other: Survey using a questionnaire.

Interventions

Survey using a questionnaire. OTHER

patients preferences survey

patients with tinnitus

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult patients (over 18 years old) with chronic, subjective severe tinnitus

You may qualify if:

• Individuals aged 18 or older suffering from subjective tinnitus
• Self-reported or healthcare professional-diagnosed chronic (lasting 3 months or longer), subjective, burdensome tinnitus

You may not qualify if:

• Individuals under 18 years of age
• Healthy volunteers without tinnitus

Sponsors & Collaborators

• Nicolas Gninenko: lead

Study Sites (1)

Neurosoft Bielectronics US Inc.

New York, New York, 10016, United States

RECRUITING

Related Links

• Related Info
• Link to access the survey

MeSH Terms

Conditions

Tinnitus; Hearing Loss; Patient Preference

Condition Hierarchy (Ancestors)

Hearing Disorders; Ear Diseases; Otorhinolaryngologic Diseases; Sensation Disorders; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Patient Satisfaction; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Nicolas Gninenko, PhD

  Neurosoft Bioelectronics

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Nicolas Gninenko, PhD

CONTACT

000-000-0000; clinical@neurosoft-bio.com

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Day
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Clinical Neuroscientist

Study Record Dates

• First Submitted: January 13, 2025
• First Posted: January 17, 2025
• Study Start: January 13, 2025
• Primary Completion (Estimated): October 30, 2026
• Study Completion (Estimated): December 30, 2026
• Last Updated: April 8, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)